Through Insights Research Organization & Solutions (IROS), the Contract Research Organization of G42 Healthcare, both the companies will conduct clinical trials and explore real-world evidence. AstraZeneca is a British-Swedish pharmaceutical and biotechnology MNC had signed a declaration of collaboration with Abu Dhabi’s Department of Health (DoH) in October 2021.
The aim is to boost UAE’s clinical research and diagnostics framework and enhance the country’s healthcare industry by increasing facilities of healthcare that would be accessed by patients easily. The collaboration with G42 (Abu Dhabi’s AI and cloud computing subsidiary firm) will help both companies to work closely on a wide range of clinical research and real-world diagnostics avenues in the UAE.
